Skip to content

Comparison of Different HES Coload Volumes on the 90% ED of Norepinephrine

Comparison of Different 6% Hydroxyethyl Starch (130/0.4) Coload Volumes on the 90% Effective Dose of Norepinephrine Infusion Prophylaxis for Hypotension During Spinal Anesthesia for Cesarean Section

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05712018
Enrollment
90
Registered
2023-02-03
Start date
2023-10-20
Completion date
2024-01-23
Last updated
2024-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Effect

Keywords

Norepinephrine, Hydroxyethyl starch 130/0.4, Postspinal anesthesia hypotension, Coload, Cesarean section

Brief summary

The purpose of this study is to investigate the effect of different 6% hydroxyethyl starch (130/0.4) coload volumes on the 90% effective dose of norepinephrine infusion prophylaxis for hypotension during spinal anesthesia for cesarean section.

Detailed description

Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylactic measures are not taken. Coload has been highly demonstrated for prevention and/or treatment of post-spinal anesthesia hypotension. In addition, there's some evidence that prophylactic infusion of norepinephrine could effectively reduce the incidence of post-spinal anesthesia hypotension in parturients undergoing cesarean section. The purpose of this study is to investigate the effect of different 6% hydroxyethyl starch (130/0.4) coload volumes on the 90% effective dose of norepinephrine infusion prophylaxis for hypotension during spinal anesthesia for cesarean section.

Interventions

DRUGHydroxyethyl starch coload - 0 ml/kg

No fluid coload was given. An initial infusion dose of prophylactic norepinephrine (0.025 ug/kg/min) simultaneous with spinal anesthesia. The dose administered to subsequent patients varied by increments or decrements of 0.005 ug/kg/min of prophylactic norepinephrine according to the responses of previous patients according to the up-down sequential allocation.

DRUGHydroxyethyl starch coload - 5 ml/kg

5 ml/kg 6% Hydroxyethyl starch (130/0.4) coload combined with an initial infusion dose of prophylactic norepinephrine (0.025 ug/kg/min) simultaneous with spinal anesthesia. The dose administered to subsequent patients varied by increments or decrements of 0.005 ug/kg/min of prophylactic norepinephrine according to the responses of previous patients according to the up-down sequential allocation.

DRUGHydroxyethyl starch coload - 10 ml/kg

10 ml/kg 6% Hydroxyethyl starch (130/0.4) coload combined with an initial infusion dose of prophylactic norepinephrine (0.025 ug/kg/min) simultaneous with spinal anesthesia. The dose administered to subsequent patients varied by increments or decrements of 0.005 ug/kg/min of prophylactic norepinephrine according to the responses of previous patients according to the up-down sequential allocation.

Sponsors

General Hospital of Ningxia Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* 18-45 years * Primipara or multipara * Singleton pregnancy ≥37 weeks * American Society of Anesthesiologists physical status classification I to II * Scheduled for cesarean section under spinal anesthesia

Exclusion criteria

* Body height \< 150 cm * Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2 * Eclampsia or chronic hypertension or baseline blood pressure ≥180 mmHg * Hemoglobin \< 7g/dl * Fetal distress, or known fetal developmental anomaly

Design outcomes

Primary

MeasureTime frameDescription
ED 501-15 minutes after spinal anesthesiaThe dose of prophylactic norepinephrine that would be effective in preventing postspinal anesthesia hypotension in 50% (effective dose, ED 50) of patients
ED 901-15 minutes after spinal anesthesiaThe dose of prophylactic norepinephrine that would be effective in preventing postspinal anesthesia hypotension in 90% (ED90) of patients

Secondary

MeasureTime frameDescription
The incidence of post-spinal anesthesia hypotension1-15 minutes after spinal anesthesiaSystolic blood pressure (SBP) \< 80% of the baseline
The incidence of severe post-spinal anesthesia hypotension1-15 minutes after spinal anesthesiaSystolic blood pressure (SBP) \< 60% of the baseline
The incidence of bradycardia1-15 minutes after spinal anesthesiaHeart rate \< 60 beats/min
Base excess (BE)Immediately after deliveryFrom umbilical arterial blood gases
The incidence of hypertension1-15 minutes after spinal anesthesiaSystolic blood pressure (SBP) \>120% of the baseline
pHImmediately after deliveryFrom umbilical arterial blood gases
Partial pressure of oxygen (PO2)Immediately after deliveryFrom umbilical arterial blood gases
The incidence of nausea and vomiting1-15 minutes after spinal anesthesiaPresence of nausea and vomiting in patients after spinal anesthesia
APGAR score1 min after deliveryA= Appearance P=Pulse G=Grimace A=Attitude R=Respiration

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026